ALB and chronic kidney disease: A significantly higher concentration of serum albumin (4.70, IQR 3.50–6.35 vs 0.80, IQR 0.80–0.80; P ═ 0.006) was seen in the group treated with rosuvastatin RD compared to the CKD control group.